Human endometrial regenerative cells alleviate carbon tetrachloride-induced acute liver injury in mice
Open Access
- 22 October 2016
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 14 (1) , 1-15
Abstract
The endometrial regenerative cell (ERC) is a novel type of adult mesenchymal stem cell isolated from menstrual blood. Previous studies demonstrated that ERCs possess unique immunoregulatory properties in vitro and in vivo, as well as the ability to differentiate into functional hepatocyte-like cells. For these reasons, the present study was undertaken to explore the effects of ERCs on carbon tetrachloride (CCl4)–induced acute liver injury (ALI). An ALI model in C57BL/6 mice was induced by administration of intraperitoneal injection of CCl4. Transplanted ERCs were intravenously injected (1 million/mouse) into mice 30 min after ALI induction. Liver function, pathological and immunohistological changes, cell tracking, immune cell populations and cytokine profiles were assessed 24 h after the CCl4 induction. ERC treatment effectively decreased the CCl4-induced elevation of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities and improved hepatic histopathological abnormalities compared to the untreated ALI group. Immunohistochemical staining showed that over-expression of lymphocyte antigen 6 complex, locus G (Ly6G) was markedly inhibited, whereas expression of proliferating cell nuclear antigen (PCNA) was increased after ERC treatment. Furthermore, the frequency of CD4+ and CD8+ T cell populations in the spleen was significantly down-regulated, while the percentage of splenic CD4+CD25+FOXP3+ regulatory T cells (Tregs) was obviously up-regulated after ERC treatment. Moreover, splenic dendritic cells in ERC-treated mice exhibited dramatically decreased MHC-II expression. Cell tracking studies showed that transplanted PKH26-labeled ERCs engrafted to lung, spleen and injured liver. Compared to untreated controls, mice treated with ERCs had lower levels of IL-1β, IL-6, and TNF-α but higher level of IL-10 in both serum and liver. Human ERCs protect the liver from acute injury in mice through hepatocyte proliferation promotion, as well as through anti-inflammatory and immunoregulatory effects.Keywords
Funding Information
- National Natural Science Foundation of China (81273257, 81471584)
- Tianjin Application Basis and Cutting-Edge Technology Research Grant (14JCZDJC35700)
- Li Jieshou Intestinal Barrier Research Special Fund (LJS_201412)
- Tianjin Medical University Talent Fund
This publication has 78 references indexed in Scilit:
- In Vivo Tracking and Comparison of the Therapeutic Effects of MSCs and HSCs for Liver InjuryPLOS ONE, 2013
- Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answersImmunology, 2012
- How mesenchymal stem cells interact with tissue immune responsesTrends in Immunology, 2012
- Derivation of Insulin Producing Cells From Human Endometrial Stromal Stem Cells and Use in the Treatment of Murine DiabetesMolecular Therapy, 2011
- Dendritic Cell Regulation of Carbon Tetrachloride–Induced Murine Liver Fibrosis RegressionHepatology, 2011
- Enhanced Liver Regeneration in IL-10–Deficient Mice after Partial Hepatectomy via Stimulating Inflammatory Response and Activating Hepatocyte STAT3The American Journal of Pathology, 2011
- Menstrual Blood Cells Display Stem Cell–Like Phenotypic Markers and Exert Neuroprotection Following Transplantation in Experimental StrokeStem Cells and Development, 2010
- Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia?Journal of Translational Medicine, 2008
- Endometrial regenerative cells: A novel stem cell populationJournal of Translational Medicine, 2007
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007